NCT06516445 2024-07-24
SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC
Huazhong University of Science and Technology
Phase 2 Recruiting
Clinical Trials
4 trialsNCT06148402 2024-05-13
Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable/Metastatic Colorectal Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting
NCT06176885 2023-12-27
FOBECAMS
Jinhua Central Hospital
Phase 2 Recruiting
NCT05202314 2023-02-21
NACSOC-02
Beijing Chao Yang Hospital
Phase NA Recruiting